Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens

Breast Cancer Research and Treatment

Volumn 87, Issue 1, 2004, Pages 59-64

  Sharma, Priyanka ^a   Klemp, Jennifer R ^a   Simonsen, Marie ^a   Welsko, Chezna M ^a   Zalles, Carola M ^b   Kimler, Bruce F ^c   Fabian, Carol J ^d  

^a Division of Hematology/Oncology   (United States)

^b Hutchison Hospital   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d Department of Anatomy and Neurology   (United States)

Author keywords

cytology; fine needle aspiration; hyperplasia; nipple aspirate fluid

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASPIRATION CYTOLOGY; BREAST CANCER; BREAST CELL; BREAST DUCT; BREAST HYPERPLASIA; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LACTATION; MAJOR CLINICAL STUDY; NIPPLE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LACTATION; MIDDLE AGED; NIPPLES; RISK FACTORS; SPECIMEN HANDLING;

EID: 4544316579     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000041582.11586.d3     Document Type: Article

References (24)

1. Page DL, Dupont WD: Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326-1335, 1990
2. Boone CW, Kelloff GJ: Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention. J Cell Biochem Suppl 17F: 37-48, 1993
3. Tavassoli FA, Norris HJ: A comparison of the results of long term follow up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Breast J 1: 155-162, 1995
4. Marshall LH, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6: 297-301, 1997
5. Fabian CJ, Kimler BF, Elledge RM, Grizzle WE, Beenken SW, Ward JH: Models for early chemoprevention trials in breast cancer. Hematol Oncol Clin North Am 12: 993-1017, 1998
6. Morrow M, Vogel V, Ljung BM, O'Shaughnessy JA: Evaluation and management of the woman with an abnormal ductal lavage. J Am College Surg 194: 648-656, 2002
7. Khan S, Baird C, Morrow M: Ductal lavage and Ductoscopy: the opportunities and the limitations. Clin Breast cancer 3: 185-191, 2002
8. O'Shaughnessy JA, Ljung BM, Dooley WC, Chang J, Kuerer HM, Hung DT, Grant MD, Khan SA, Phillips RF, Duvall K, Euhus DM, King BL, Anderson BO, Troyan SL, Kim J, Veronesi U, Cazzaniga M: Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary. Cancer 94: 292-298, 2002
9. Fabian CJ, Kimler BF: Breast cancer chemoprevention: current challenges and a look towards the future. Clin Breast Cancer 3: 113-124, 2002
10. Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS: Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 92: 1217-1227, 2000
11. Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB: Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 93: 1624-1632, 2001
12. Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M: Breast cancer risk in women with abnormal cytology in nipple aspirates of beast fluid. J Natl Cancer Inst 93: 1791-1798, 2001
13. Klein P, Glaser E, Grogan L, Kirsch I: Biomarker assay in nipple aspirate fluid. The Breast J 7: 378-387, 2001
14. Gann P, Chatterton R, Vogelsong K, Ellman A: Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of viability. Cancer Epidemiol Biomarkers Prevention 6: 421-428, 1997
15. Harding C, Osundeko O, Tetlow I, Bundred NJ: Hormonally regulated proteins in breast secretions are markers of target organ sensitivity. Br J Cancer 82: 354-360, 2000
16. Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H: Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76: 494-501, 1997
17. Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, Hauck WW: Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat 15: 39-51, 1990
18. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886, 1989
19. Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91: 1829-1846, 1999
20. Zalles C, Kimler BF, Kamel S, McKittrick R, Fabian CJ: Cytologic patterns in random aspirates from women at high and low risk for breast cancer. The Breast J 1: 343-349, 1995
21. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB: Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 66: 1480-1487, 1990
22. Masood S: Cytomorphology of fibrocystic change, high risk, and premalignant breast lesions. Breast J 1: 210-221, 1995
23. The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. Diagn Cytopathol 16: 295-311, 1997
24. Wrensch M, Petrakis NL, King EB, Lee MM, Miike R: Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy. Am J Epidemiol 137: 829-833, 1993